What if you could see every road cancer takes — and block every escape route?
In this episode of Outsmart Cancer, Dr. Dino Prato, founder of Envita Medical Centers, reveals how deep mapping and multi-omics testing help doctors “knock out cancer” by identifying every pathway, mutation, and immune barrier that fuels disease growth. Using DNA sequencing, RNA transcriptomics, and spatial biology, Dr. Prato explains how this technology builds a “drone view” of the tumor and its surrounding environment to design truly personalized precision oncology.
Instead of relying on one-size-fits-all chemotherapy, Envita’s deep mapping approach customizes drug design, dosing, and delivery to each patient’s unique tumor biology — combining microdosed chemo, direct-to-tumor delivery (CIPI), and immune-based cell therapies (AAIT) to create safer, more targeted outcomes.
🎯 What You’ll Learn in This Episode:

• What “deep mapping” means in cancer treatment
• Why DNA testing alone isn’t enough — you need RNA and spatial biology
• How Envita designs multi-drug, multi-pathway treatment plans
• How microdosing, interventional oncology, and immune therapy work together
• Why precision targeting achieved 35x higher response rates in published data*

*(See Outcomes Disclaimer Below)
📊 Precision oncology helps patients eliminate guesswork, reduce side effects, and achieve higher response rates through smarter, individualized cancer care.
“Deep mapping turns guesswork into precision — and precision into hope.”

Disclaimer
This podcast is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult your licensed healthcare provider before making any medical decisions. Individual results will vary, and Envita Medical Centers does not guarantee outcomes. Some treatments discussed may not be FDA-approved or available in all locations. Testimonials are shared with patient consent and may not reflect typical results. Do not delay or disregard professional medical care based on the podcast's content. Certain treatments may be available only at Envita’s international clinic in Hermosillo, Mexico. No specific outcomes are promised or implied.
________________________________________
Outcomes Disclaimer
The results referenced from Envita's Precision Cancer Care: 35-Fold Improvement in Response Rates are from a retrospective analysis of 199 late-stage cancer patients treated at Envita Medical Centers between 2021 and 2023, as published in the Journal of Cancer Therapy. These outcomes are not guaranteed and will vary based on individual factors such as cancer type, stage, genetics, immunity and prior treatments. Any comparisons to standard care or clinical trials are based on published data and internal analysis, not head-to-head studies. Individual results will vary.

You can read the full peer-reviewed study at:

https://www.scirp.org/journal/paperinformation?paperid=132493